Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study
A drug repurposing strategy could be a potential approach to overcoming the economic costs for diabetes mellitus (DM) treatment incurred by most countries. DM has emerged as a global epidemic, and an increase in the outbreak has led developing countries like Mexico, India, and China to recommend a p...
שמור ב:
Main Authors: | , , , , |
---|---|
פורמט: | ספר |
יצא לאור: |
MDPI AG,
2019-05-01T00:00:00Z.
|
נושאים: | |
גישה מקוונת: | Connect to this object online. |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
אינטרנט
Connect to this object online.3rd Floor Main Library
סימן המיקום: |
A1234.567 |
---|---|
עותק 1 | זמין |